Stage IV HER2-Positive Breast Cancer: Tiffany's Patient Story

Patient Info: Tiffany Andrews, Female, Under 40 | Stage IV

Biomarkers: HER2-positive; ER-negative at recurrence

Metastatic Site: lungs|brain

Tiffany is living with metastatic HER2-positive breast cancer and continues treatment through a clinical trial after progression in the lungs and brain.

MD AndersonRead more →

Triple-Negative Breast Cancer: Halassy's Survivor Story

Patient Info: Halassy, Female, 50s

Biomarkers: triple-negative

In remission for 45 months after surgery for the recurrent tumor.

PubMed CentralRead more →

Stage III Invasive Lobular Carcinoma: Betsy's Patient Story

Patient Info: Betsy | Stage III

Betsy continues long-term hormone therapy with anastrozole after almost 2 years of tamoxifen.

Lobular Breast Cancer AllianceRead more →

Stage II Breast Cancer: Naomi's Patient Story

Patient Info: Naomi Arbel-Brodd, Female | Stage II

Twenty years after her 2006 diagnosis, she had returned to UT MD Anderson as a weekly volunteer supporting other women receiving breast cancer care.

MD AndersonRead more →

HER2-Positive Breast Cancer Treatment Followed by Multiple Myeloma

Patient Info: Anonymized, female, 50s | Stage II

Biomarkers: ER-negative; PR-negative; HER2 3+; Ki-67 70%

Postoperative imaging showed no breast cancer recurrence or distant metastasis, and the breast cancer was described as stable when a separate multiple myeloma diagnosis was made.

PubMed CentralRead more →

Breast cancer treatment changed after severe colitis

Patient Info: Anonymized, Female, 50s | Stage II

Biomarkers: HER2-positive, ER-negative, PR-negative

In April 2025, follow-up evaluation showed no evidence of breast cancer recurrence.

PubMed CentralRead more →

Stage III Invasive Lobular Carcinoma: Famke's Survivor Story

Patient Info: Famke, Female, Under 40 | Stage III

Famke received surgery, chemotherapy and radiation and celebrated 5 years since diagnosis while continuing long-term hormone therapy.

Lobular Breast Cancer AllianceRead more →

Stage I Breast Cancer: Tamara's Patient Story

Patient Info: Tamara Mitchell, Female | Stage I

Tamara continued annual breast cancer screening while her leukemia and kidney cancer were being managed separately.

MD AndersonRead more →

Rare Breast Neuroendocrine Cancer That Recurred in the Liver

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: Chromogranin-positive; synaptophysin-positive; GATA-3-positive; ER-positive; PR negative on repeat biopsy and 40% positive on the mastectomy specimen; HER2-negative; Ki-67 85–95%

Metastatic Site: Liver; abdominal lymph nodes

After temporary responses to surgery and repeated chemotherapy, the cancer returned repeatedly in the liver and had spread to abdominal lymph nodes by May 2025. A new chemotherapy regimen was planned.

PubMed CentralRead more →

Stage II Triple-Negative Breast Cancer: Melissa's Survivor Story

Patient Info: Melissa, Female | Stage II

Biomarkers: Triple-negative breast cancer; BRCA testing negative; NBN gene mutation identified on later testing

Melissa completed pregnancy-adapted cancer treatment, later underwent risk-reducing surgery and reconstruction, and was raising both daughters.

The Patient StoryRead more →

Stage IV HR-Positive Breast Cancer: Alison's Survivor Story

Patient Info: Alison, Female, Under 40 | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-positive

Metastatic Site: Cervical/neck lymph nodes

Alison reported complete remission since August 2017 while continuing intermittent maintenance chemotherapy, most recently 1 month of treatment followed by 2 months off.

The Patient StoryRead more →

Stage III HR-Positive Invasive Ductal Carcinoma: Stefanie's Survivor Story

Patient Info: Stefanie, Female | Stage III

Biomarkers: ER-positive, PR-positive and HER2-positive

Stefanie completed chemotherapy, breast-conserving surgery, prolonged Herceptin and 30 radiation treatments, then moved into survivorship while still adjusting to the lasting effects of treatment.

The Patient StoryRead more →

Stage IV HR-Positive Invasive Ductal Carcinoma: Shari's Patient Story

Patient Info: Shari S., Female | Stage IV

Biomarkers: ER-positive, PR-positive and HER2-positive; no inherited cancer mutation was identified

Metastatic Site: Brain; other initial metastatic sites were not named

Systemic imaging after chemotherapy showed no active disease, but brain metastases later required stereotactic radiation. Shari remained stage 4, continued Herceptin every 3 weeks and underwent brain MRI every 3–4 months.

The Patient StoryRead more →

Stage II Breast Cancer: Renée's Survivor Story

Patient Info: Renée, Female, Under 40 | Stage II

Renée described her health as stable and her treatment as working. She remained on a long-term hormone-based anti-cancer regimen and was still healing from reconstruction complications rather than describing herself as cancer-free.

The Patient StoryRead more →

Stage II Triple-Negative Breast Cancer: Lucy's Survivor Story

Patient Info: Lucy, Female, Under 40 | Stage II

Biomarkers: Germline BRCA1 mutation; triple-negative breast cancer

Surgical pathology was all clear on June 17 after a strong chemotherapy response. Lucy described herself as cancer-free and continued oncology reviews every 3–4 months while planning delayed reconstruction.

The Patient StoryRead more →

Stage II Breast Cancer: Wendi's Survivor Story

Patient Info: Wendi Kushner | Stage II

Biomarkers: Triple-positive

After the clinical trial, lumpectomy pathology showed a complete pathological response with no residual cancer in the breast or lymph nodes.

MD AndersonRead more →

Breast cancer treatment in a woman with mirror-image organ anatomy

Patient Info: Anonymized, Female

Biomarkers: ER-positive; HER2-negative

A woman in her early 60s with mirror-image organ anatomy received chemotherapy and mastectomy for left breast cancer after a specially planned venous port placement.

PubMed CentralRead more →

Stage I Invasive Lobular Carcinoma: Jen's Survivor Story

Patient Info: Jen, Female, 50s | Stage I

Jen completed 2 operations and radiation for a 3.5 mm stage 1 lobular breast cancer and then entered post-treatment follow-up.

Lobular Breast Cancer AllianceRead more →

Invasive Ductal Carcinoma: Shelby's Patient Story

Patient Info: Shelby, Female, Under 40

As of June 2026, Shelby had undergone double mastectomy and AC chemotherapy during pregnancy as a surrogate and delivered a healthy baby; long-term cancer status was not clearly stated.

The Patient StoryRead more →

Hormone receptor-positive, HER2-positive breast cancer treatment interrupted by vaginal cuff dehiscence and bowel evisceration

Patient Info: Anonymized, Female, 70+ | Stage III

Biomarkers: Hormone receptor-positive; HER2-positive

At 21 months after emergency repair, she was symptom-free with POP-Q stage 0; letrozole continued and T-DM1 was resumed 7 weeks after discharge, but long-term cancer response was not detailed.

PubMed CentralRead more →

Stage IIA triple-negative neuroendocrine breast carcinoma with chemoimmunotherapy response

Patient Info: Anonymized, Female, 70+ | Stage II

Biomarkers: Triple-negative neuroendocrine breast carcinoma with PD-L1 CPS >=10, and reported germline BRCA1/2 mutation.

As of March 2025, 12 months after surgery, follow-up imaging and tumor-marker testing showed no local recurrence or distant metastasis, and she remained in good general condition.

PubMed CentralRead more →

Triple-Negative Breast Cancer: Kim's Survivor Story

Patient Info: Kim Rumpf, Female

Biomarkers: ER-negative; PR-negative; HER2-negative

As of June 2026, Kim Rumpf was a triple-negative breast cancer survivor sharing her experience with chemotherapy, double mastectomy, reconstruction, fertility challenges, and advocacy.

Stage IV HER2-Positive Invasive Ductal Carcinoma: Renee's Patient Story

Patient Info: Renee N., Female | Stage IV

Biomarkers: HER2-positive

Metastatic Site: Brain

As of June 2026, Renee’s public story described living with metastatic HER2-positive breast cancer as a chronic illness, after brain radiation and while on Kadcyla every 3 weeks with stable scans reported in December 2019 and early March 2020.

The Patient StoryRead more →

Stage I Invasive Ductal Carcinoma: Rachel's Patient Story

Patient Info: Rachel, Female | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

As of June 2026, Rachel had completed double mastectomy and chemotherapy for Stage IB breast cancer and remained on planned 10-year tamoxifen therapy, with ongoing joint/muscle pain, weight gain, and survivorship effects.

The Patient StoryRead more →